“`html
On September 18, 2025, Guggenheim initiated coverage of Immatics N.V. (NasdaqCM:IMTX) with a Buy recommendation, suggesting a potential upside of 113.83%. The average one-year price target for Immatics is set at $14.13 per share, a significant increase from its latest closing price of $6.61 per share.
Projected annual revenue for Immatics is $141 million, an increase of 8.72%, with a non-GAAP EPS forecast of -0.27. Institutional ownership has decreased to 109 funds, a drop of 18 owners (14.17%) in the last quarter, while total shares owned by institutions have increased by 1.26% to 98,918K shares.
Significant shareholders include T. Rowe Price Investment Management with 15.08% ownership (18,328K shares), Suvretta Capital Management holding 9.90% (12,030K shares), and Baker Bros. Advisors owning 8.37% (10,169K shares), with each firm increasing their holdings in the last quarter.
“`
